In contrast, the PRAME mRNA and protein were obviously overexpressed in the HPV-negative C33A cell line and HPV-negative cervical cancer tissues, implying that PRAME may represent a potential biomarker only for HPV-negative cervical cancers. This evidence concerns the gene PRAME and cervical cancer.